Neulasta® Prefilled Syringe for Febrile Neutropenia Prevention

Neulasta® is a long-acting form of pegfilgrastim used with chemotherapy. It helps lower the risk of infection by boosting white blood cells during treatment. You can access Canadian pricing with US delivery from Canada, and see options that may fit your budget without insurance.

What Neulasta Is and How It Works

This medicine is a granulocyte colony-stimulating factor. It signals your bone marrow to produce more neutrophils, which help fight bacteria. The goal is to reduce the chance of febrile neutropenia during myelosuppressive chemotherapy.

YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing.

The active ingredient is pegfilgrastim, a pegylated version of filgrastim. The pegylation makes the drug last longer in the body, allowing once-per-cycle dosing. Labeling indicates it should be used for patients with non-myeloid cancers who are receiving chemotherapy known to cause significant neutropenia.

When discussing budgets, some people search for Pegfilgrastim 6 mg price. We list transparent details on the product page, including formulation and pack information.

Learn more about the condition this therapy supports in our overview of Febrile Neutropenia and Neutropenia. For broader oncology needs, see our Cancer category.

Who It’s For

This treatment is intended for adults and children with non-myeloid malignancies on myelosuppressive chemotherapy. It is used to lower the incidence of infection as shown by fever and low neutrophils. Your clinician may recommend it when the expected risk of febrile neutropenia is clinically significant.

People who should avoid this drug include anyone with a known serious allergy to pegfilgrastim or filgrastim. Tell your clinician about a history of severe allergic reactions, splenic problems, sickle cell disease, or previous issues with G-CSF products. If pregnant or breastfeeding, discuss potential risks and benefits before starting.

For related reading on supportive oncology, see Aranesp Prefilled Syringe and our guide to Leukemia Overview.

Dosage and Usage

Use this injection exactly as prescribed. The usual adult schedule is a single subcutaneous dose once per chemotherapy cycle. It is given at least 24 hours after cytotoxic chemotherapy. Do not administer within the 14 days before chemotherapy. Pediatric dosing is weight-based; your prescriber will select the appropriate volume.

Administration steps typically include allowing the syringe to reach room temperature as directed on the label, inspecting the solution, choosing an approved site such as the abdomen or thigh, cleaning the skin, and injecting subcutaneously. Rotate sites. Do not shake the syringe.

For patients researching budgets, we provide clarity beyond list numbers and explain how the Pegfilgrastim 6 mg price can vary by pack and supply planning.

For general technique tips, our step-by-step injection article may help build confidence: How To Inject: Step-by-Step.

Strengths and Forms

The product is supplied as a single-dose prefilled syringe with UltraSafe Guard. A commonly published presentation is 6 mg/0.6 mL for subcutaneous use. Availability can vary by manufacturer lot and market supply.

Device features may include a needle guard that helps cover the needle after injection. Each syringe is for one-time use only.

Missed Dose and Timing

If you miss a scheduled injection, contact your clinician for guidance. Timing around chemotherapy is important. Do not inject within the 14 days before chemo, and do not take it until at least 24 hours after chemotherapy has finished. If you are unsure about the timing, reach your care team before using the syringe.

Report fever, new pain, shortness of breath, or any concerning symptoms promptly, especially during periods of low white blood cell counts.

Storage and Travel Basics

Store the syringe in a refrigerator according to the label. Keep it in the original carton to protect from light. Do not shake. If the solution looks cloudy, discolored, or contains particles, do not use it. Keep out of reach of children.

Travel with a copy of your prescription and a plan for refrigeration. Use an insulated bag with cold packs to maintain label-recommended conditions. Do not place the syringe directly on ice. If travel delays occur, contact your pharmacist or clinician about what to do next.

For more injection-related safety information, see our piece on biologic therapy handling: Enbrel Injection.

Pen Handling and Sharps Disposal

This is a prefilled syringe, not a pen, but similar safety rules apply. Inspect the device carefully before use. Do not use if the cap is missing or the guard seems damaged. Follow the patient instructions for the UltraSafe Guard device while injecting.

• Safe setup: prepare supplies and clean the site
• Single use only: never reuse a syringe
• Needle safety: the guard should deploy after injection
• Sharps disposal: place the used device into an FDA-cleared sharps container
• Local rules: follow community guidance for sharps drop-off or mail-back

Benefits

This therapy helps reduce the risk of febrile neutropenia during susceptible chemotherapy cycles. A long-acting profile means one injection per cycle for most adults. The device’s guarded needle adds an extra layer of protection during handling. Supporting neutrophil recovery can help your cancer team maintain the planned chemotherapy intensity when appropriate.

For context on oncology regimens that sometimes pair with supportive care, explore our article on Ibrance Palbociclib and this overview of Scemblix Tablet.

Side Effects and Safety

Common effects include bone pain, muscle aches, headache, fatigue, and injection-site reactions. These are usually mild to moderate. Over-the-counter options may be suggested by your clinician if appropriate. If pain worsens or persists, contact your care team.

Serious risks are uncommon but can include splenic rupture, severe allergic reactions, adult respiratory distress syndrome, aortitis, glomerulonephritis, capillary leak syndrome, and sickle cell crises. Seek urgent care for left upper abdominal pain, trouble breathing, swelling, sudden weight gain, or a severe rash. Leukocytosis can occur; your team will monitor counts.

If you have a history of latex allergy, tell your clinician before use. Always follow the official prescribing information for the most accurate safety details.

Drug Interactions and Cautions

Few drug-drug interactions are clinically significant. Lithium may increase white blood cell production and could amplify effects. Do not inject on the same day as cytotoxic chemotherapy. Tell your healthcare professional about all medicines, vitamins, and supplements you take. Use caution if you have underlying lung disease or a history of severe allergies.

Use only under the supervision of a qualified prescriber. Monitoring with complete blood counts is standard during chemotherapy.

What to Expect Over Time

Counts typically recover during each cycle when therapy is timed correctly. Bone pain may occur as neutrophils increase; your clinician may suggest supportive measures. Keep track of your injection schedule alongside chemotherapy dates. Good adherence helps your team manage infection risk.

If circumstances change, such as delays in chemotherapy or a new infection, inform your clinic. They may adjust timing to align with the treatment plan.

Compare With Alternatives

Several pegfilgrastim products are approved. Biosimilars offer comparable efficacy and safety per regulatory standards. Two options we carry include Omlyclo and Nypozi. Your prescriber may choose among them based on clinical experience, device features, and formulary access.

Pricing and Access

We display clear details so you can compare options and plan refills. Check the Neulasta prefilled syringe price on the product page, then review support resources if needed. You can also reference Neulasta Canadian pricing when discussing choices with your care team.

We highlight practical ways to manage expenses, including biosimilar considerations and combining items in one parcel. For limited-time offers, see our Promotions page. We provide US shipping from Canada with prescription validation.

Availability and Substitutions

Supply can vary. If this item is temporarily unavailable, a prescriber may recommend a therapeutically appropriate alternative within the same class. This could include a pegfilgrastim biosimilar if suitable. Talk with your clinician about interchangeability and device preferences. When ready, you may choose to Order Neulasta syringe online after your prescription is received and assessed.

Patient Suitability and Cost-Saving Tips

Good candidates are those receiving myelosuppressive chemotherapy with a clinically significant risk of febrile neutropenia. Those with a history of severe allergy to G-CSF agents should avoid it. Patients with sickle cell disease or prior splenic issues need careful evaluation.

• Plan ahead: align injection timing with chemo dates
• Lower costs: discuss biosimilars and Neulasta self pay options
• Bundle items: combine orders to reduce per-parcel fees
• Refill reminders: set alerts after each infusion visit
• Storage planning: prepare cooling for travel days
• Documentation: keep a copy of your prescription while traveling

Our checkout is secure, and your prescription is required and verified before fulfilment.

Questions to Ask Your Clinician

• Is this medicine right for my chemotherapy regimen and risk level?
• How should I time the injection in relation to my chemo schedule?
• What signs of infection or rare complications should I watch for?
• Could a biosimilar be appropriate for me?
• Which injection site do you recommend, and can you review my technique?
• How will you monitor blood counts during treatment?
• What is the plan if my next chemo cycle is delayed?

Authoritative Sources

• Amgen (Manufacturer)
• FDA DailyMed Prescribing Information
• Health Canada Drug Product Database

Ready to proceed?

Place your order today for Ships from Canada to US with prompt, express, cold-chain shipping. This content is for general information only and does not replace your clinician’s advice.